Posted on 7/14/20
TriNetX Signs Agreement with FDA Sentinel Program
TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced the signing of an . . .
Posted on 7/14/20
Blueprint Medicines Announces Global Collaboration with Roche
Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that it has entered into . . .
Posted on 7/14/20
NVNA and Hospice Earns SHPBest "Superior Performer" Patient Satisfaction Award from Strategic Healthcare Programs
NVNA and Hospice, a non-profit home health care and hospice agency serving 27 communities on the South Shore, today announced it has earned the SHPBest "Superior . . .
Posted on 7/14/20
Aldeyra Therapeutics Announces Stock Sales to Perceptive Advisors and Avidity Partners
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases, . . .
Posted on 7/14/20
Thermo Fisher Under Mounting Pressure To Up Qiagen Bid - UFP
United First Partners chief Stephane Mardel says bullish preliminary results from life science toolmaker PerkinElmer (PKI +3.5%) is ratcheting up the pressure on Thermo Fisher Scientific . . .
Posted on 7/13/20
EyePoint Pharmaceuticals Appoints Jay Duker as Chief Strategic Scientific Officer
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced the appointment of Jay S. Duker, M.D.,
Posted on 7/13/20
Major League Lacrosse Partners with Biodesix
BOSTON & BOULDER, Colo.--(BUSINESS WIRE)--Major League Lacrosse (MLL) today announced a partnership with Biodesix, Inc., whereby Biodesix will be the exclusive provider of COVID-19 testing for . . .
Posted on 7/13/20
Dewpoint Therapeutics Collaborates with Merck
BOSTON--(BUSINESS WIRE)--Dewpoint Therapeutics, the biomolecular condensates company, announced today that it has forged an exclusive collaboration agreement with Merck, known as MSD outside the United States . . .
Posted on 7/13/20
Amwell Honors Telehealth Innovation and Clinical Care Excellence with Annual Client Award Program
Today, Amwell, a national telehealth leader, announced the recipients of its annual Client Awards. Awards were given to organizations that have made exceptional contributions to expanding . . .
Posted on 7/13/20
Thermo Fisher Bid For Qiagen Inadequate - Davidson Kempner
QIAGEN N.V. (QGEN +1.3%) is up modestly, albeit on below-average volume, on the heels of a letter to its board from institutional investor Davidson Kempner stating . . .
Posted on 7/13/20
IPO Update: Relay Therapeutics Seeks $250 Million In IPO
SummaryRelay Therapeutics had filed proposed terms for a $250 million IPO of its common stock.The firm is advancing treatment candidates for various solid tumors.RLAY is still . . .
Posted on 7/13/20
Moderna's COVID-19 Vaccine And Other News: The Good, Bad And Ugly Of Biopharma
SummaryModerna completes enrolment in its covid-19 vaccine trial.Palatin resumes midstage dry eye study.Viveve gets FDA's go ahead for CMRF trial.Looking for more stock ideas like this . . .
Posted on 7/12/20
Therapeutics Acquisition Corp., Sponsored by RA Capital Management Closes $135.7M IPO
BOSTON--(BUSINESS WIRE)--Therapeutics Acquisition Corp. (Nasdaq: TXAC) announced today that on July 10, 2020 it closed its initial public offering of 13,570,000 shares of Class A common . . .
Posted on 7/12/20
ViralClear Pharmaceuticals Partners with Albany Molecular Research
Westport, CT, July 08, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) and its subsidiary, ViralClear Pharmaceuticals, Inc., today announced that it is partnering with . . .
Posted on 7/10/20
NeuroMetrix Announces Expanded Distribution Of DPNCheck In China
NeuroMetrix (NURO +3.6%) announces that Omron Medical (Beijing) Ltd., its exclusive distributor of peripheral neuropathy test device DPNCheck in China, has inked a collaboration agreement with . . .
Posted on 7/10/20
Lyra Therapeutics: Advancing An Innovative Solution For Chronic Rhinosinusitis
SummaryLyra Therapeutics went public in May of 2020 at $16 a share and is advancing LYR-210 for the treatment of rhinosinusitis.LYR-210 is an implantable steroid infused . . .
Posted on 7/9/20
Kymera Therapeutics And Sanofi Enter Into Strategic Partnership
Kymera Therapeutics Inc. today announced the company has entered into a multi-program strategic collaboration with Sanofi (NASDAQ: SNY) to develop and commercialize first-in-class protein degrader therapies . . .
Posted on 7/9/20
DRADS Capital Leads Series C Round for ROKIT Healthcare
SEOUL, South Korea--(BUSINESS WIRE)--DRADS Capital announced today its investment in ROKIT Healthcare Inc., a South Korean biotechnology company developing innovative 4D bioprinting techniques and applications, in . . .
Posted on 7/9/20
Biogen: A Mix Of Growth And Stability
SummaryBiogen recently announced that it will begin FDA approval on its Alzheimer's disease drug aducanumab in the third quarter 2020.The company experienced a setback in working . . .
Posted on 7/9/20
Ocular Therapeutix Is A Good Value Based On Its Strong Technology Platform
SummaryOcular Therapeutix already has one marketed product and several promising pipeline therapies using its novel implant technology for the treatment of eye diseases.Ocular's wet AMD treatment . . .
Posted on 7/9/20
Better Buy: AbbVie vs. Biogen
AbbVie (NYSE:ABBV) and Biogen (NASDAQ:BIIB) are two drugmakers that have moved in opposite directions on the stock market of late. While AbbVie has rebounded nicely from . . .
Posted on 7/9/20
Biogen Lifts Nasdaq to Near-Record; JD.com Leads China Internet Stocks Higher
The stock market has gotten back some of its turbulence, but the Nasdaq Composite (NASDAQINDEX:^COMP) has maintained its leadership role. Even as other major market benchmarks . . .
Posted on 7/9/20
Biogen Shares Spike on Alzheimer's Update
The first new drug application for an experimental therapy meant to prevent Alzheimer's disease from worsening finally reached regulators on Wednesday. Biogen (NASDAQ:BIIB) has finally submitted . . .
Posted on 7/8/20
Why Novavax Is Outperforming Moderna
Buying momentum slowed considerably after Moderna (MRNA) shares topped $80.00. The management's timing of a stock sale worsened investor trust. Since the $87.00 peak in May . . .
Posted on 7/19/20
Concert Pharmaceuticals Receives FDA Breakthrough Therapy Designation
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for the Company’s oral Janus kinase inhibitor, . . .
Boston
